skip to main content

Therapeutic advances in atrial fibrillation based on animal models

Gong, Qian ; Le, Xuan ; Yu, Pengcheng ; Zhuang, Lenan

Journal of Zhejiang University. B. Science, 2024-02, Vol.25 (2), p.135-152 [Periódico revisado por pares]

Hangzhou: Zhejiang University Press

Texto completo disponível

Citações Citado por
  • Título:
    Therapeutic advances in atrial fibrillation based on animal models
  • Autor: Gong, Qian ; Le, Xuan ; Yu, Pengcheng ; Zhuang, Lenan
  • Assuntos: Animal models ; Animal species ; Animals ; Arrhythmia ; Atrial Fibrillation - drug therapy ; Biomedical and Life Sciences ; Biomedicine ; Cardiac arrhythmia ; Disease Models, Animal ; Dogs ; Fibrillation ; Horses ; Humans ; Pathogenesis ; Rare species ; Review ; Swine ; Therapeutic applications ; Treatment Outcome
  • É parte de: Journal of Zhejiang University. B. Science, 2024-02, Vol.25 (2), p.135-152
  • Notas: ObjectType-Article-2
    SourceType-Scholarly Journals-1
    ObjectType-Feature-3
    content type line 23
    ObjectType-Review-1
  • Descrição: Atrial fibrillation (AF) is the most prevalent sustained cardiac arrhythmia among humans, with its incidence increasing significantly with age. Despite the high frequency of AF in clinical practice, its etiology and management remain elusive. To develop effective treatment strategies, it is imperative to comprehend the underlying mechanisms of AF; therefore, the establishment of animal models of AF is vital to explore its pathogenesis. While spontaneous AF is rare in most animal species, several large animal models, particularly those of pigs, dogs, and horses, have proven as invaluable in recent years in advancing our knowledge of AF pathogenesis and developing novel therapeutic options. This review aims to provide a comprehensive discussion of various animal models of AF, with an emphasis on the unique features of each model and its utility in AF research and treatment. The data summarized in this review provide valuable insights into the mechanisms of AF and can be used to evaluate the efficacy and safety of novel therapeutic interventions.
  • Editor: Hangzhou: Zhejiang University Press
  • Idioma: Inglês;Chinês

Buscando em bases de dados remotas. Favor aguardar.